Welcome to CDC stacks | Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam - 31825 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam
Filetype[PDF-286.54 KB]


No Related Documents.
You May Also Like:
  1. Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam
    Personal Author:
    Van Hong, Nguyen; Amambua-Ngwa, Alfred; Tuan, Nguyen Quang; Cuong, Do Duy; Giang, Nguyen Thi Huong; Van Dung, Nguyen; Tinh, Ta Thi; Van Tien, Nguyen; Phuc, Bui Quang; Duong, Tran Thanh; Rosanas-Urgell, Anna; Van Geertruyden, Jean-Pierre; D’Alessandro, Umberto; Erhart, Annette;
    Published:
    Jul 2015
    Source:
    Emerg Infect Dis. 21(7):1265.
    File Type:
    Filetype[PDF - 218.97 KB]
  2. Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam
    Personal Author:
    Van Hong, Nguyen; Amambua-Ngwa, Alfred; Tuan, Nguyen Quang; Cuong, Do Duy; Giang, Nguyen Thi Huong; Van Dung, Nguyen; Tinh, Ta Thi; Van Tien, Nguyen; Phuc, Bui Quang; Duong, Tran Thanh; Rosanas-Urgell, Anna; D’Alessandro, Umberto; Van Geertruyden, Jean-Pierre; Erhart, Annette;
    Published:
    Jul 2014
    Source:
    Emerg Infect Dis. 20(7):1207-1210.
    Description:
    Resistance to artemisinin derivatives, the most potent antimalarial drugs currently used, has emerged in Southeast Asia and threatens to spread to Africa. We report a case of malaria in a man who returned to Vietnam after 3 years in Angola that did n...
    File Type:
    Filetype[PDF - 403.65 KB]
  3. Efficacy of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015
    Personal Author:
    Plucinski, Mateusz M.; Dimbu, Pedro Rafael; Macaia, Aleixo Panzo; Ferreira, Carolina Miguel; Samutondo, Claudete; Quivinja, Joltim; Afonso, Marília; Kiniffo, Richard; Mbounga, Eliane; Kelley, Julia S.; Patel, Dhruviben S.; He, Yun; Talundzic, Eldin; Garrett, Denise O.; Halsey, Eric S.; Udhayakumar, Venkatachalam; Ringwald, Pascal; Fortes, Filomeno;
    Published:
    Feb 02 2017
    Source:
    Malar J. 16.
    Description:
    Background : Recent anti-malarial resistance monitoring in Angola has shown efficacy of artemether–lumefantrine (AL) in certain sites approaching the key 90% lower limit of efficacy recommended for artemisinin-based combination therapy. In addition...
    File Type:
    Filetype[PDF - 1.21 MB]
  4. The challenge of artemisinin resistance can only be met by eliminating Plasmodium falciparum malaria across the Greater Mekong subregion
    Personal Author:
    Smith Gueye, Cara; Newby, Gretchen; Hwang, Jimee; Phillips, Allison A; Whittaker, Maxine; MacArthur, John R; Gosling, Roly D; Feachem, Richard GA;
    Published:
    Jul 27 2014
    Source:
    Malar J. 2014; 13:286.
    Description:
    Artemisinin-based combinations are currently the most effective anti-malarials and, in addition to vector control, have led to significant declines in malaria morbidity and mortality. However, foci of artemisinin drug resistance have been identified ...
    File Type:
    Filetype[PDF - 357.29 KB]
  5. Artesunate Misuse and Plasmodium falciparum Malaria in Traveler Returning from Africa
    Personal Author:
    Shahinas, Dea; Lau, Rachel; Khairnar, Krishna; Hancock, David; Pillai, Dylan R.;
    Published:
    Oct 2010
    Source:
    Emerg Infect Dis. 16(10):1608-1610.
    Description:
    Plasmodium falciparum malaria developed in an African-born traveler who returned to Canada after visiting Nigeria. While there, she took artesunate prophylactically. Isolates had an elevated 50% inhibitory concentration to artemisinin, artesunate, an...
    File Type:
    Filetype[PDF - 219.20 KB]